Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma.
Bold, A; Gaertner, J; Bott, A; Mordstein, V; Schaefer-Eckart, K; Wilhelm, M;
J Immunother. 2023; 46(2):56-58
Fallberichte

Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy.
Falk, M; Willing, E; Schmidt, S; Schatz, S; Galster, M; Tiemann, M; Ficker, JH; Brueckl, WM;
Curr Oncol. 2023; 30(2):1692-1698
Fallberichte

How I treat diffuse large B-cell lymphoma.
Melchardt, T; Egle, A; Greil, R;
ESMO Open. 2023; 8(1):100750
Übersichtsarbeiten

Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
Franklin, C; Mohr, P; Bluhm, L; Grimmelmann, I; Gutzmer, R; Meier, F; Garzarolli, M; Weichenthal, M; Pfoehler, C; Herbst, R; Terheyden, P; Utikal, J; Ulrich, J; Debus, D; Haferkamp, S; Kaatz, M; Forschner, A; Leiter, U; Nashan, D; Kreuter, A; Sachse, M; Welzel, J; Heinzerling, L; Meiss, F; Weishaupt, C; Gambichler, T; Weyandt, G; Dippel, E; Schatton, K; Celik, E; Trommer, M; Helfrich, I; Roesch, A; Zimmer, L; Livingstone, E; Schadendorf, D; Horn, S; Ugurel, S
J IMMUNOTHER CANCER. 2022; 10(6):
Originalarbeiten (Zeitschrift)

Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Goldinger, SM; Buder-Bakhaya, K; Lo, SN; Forschner, A; McKean, M; Zimmer, L; Khoo, C; Dummer, R; Eroglu, Z; Buchbinder, EI; Ascierto, PA; Gutzmer, R; Rozeman, EA; Hoeller, C; Johnson, DB; Gesierich, A; Koelblinger, P; Bennannoune, N; Cohen, JV; Kahler, KC; Wilson, MA; Cebon, J; Atkinson, V; Smith, JL; Michielin, O; Long, GV; Hassel, JC; Weide, B; Haydu, LE; Schadendorf, D; McArthur, G; Ott, PA; Blank, C; Robert, C; Sullivan, R; Hauschild, A; Carlino, MS; Garbe, C; Davies, MA; Menzies, AM
EUR J CANCER. 2022; 162: 22-33.
Originalarbeiten (Zeitschrift)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov, B; Stana, M; Kaiser, B; Karner, J; Gerum, S; Ruznic, E; Zellinger, B; Moosbrugger, R; Studnicka, M; Fastner, G; Sedlmayer, F; Zehentmayr, F;
Cancers (Basel). 2022; 14(3):
Übersichtsarbeiten

Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Hauer, L; Sellner, J
DRUG DES DEV THER. 2022; 16: 3915-3927.
Übersichtsarbeiten

Tafasitamab mediates killing of B-cell non-Hodgkinxxxs lymphoma in combination with gamma delta T cell or allogeneic NK cell therapy
Her, JH; Pretscher, D; Patra-Kneuer, M; Schanzer, J; Cho, SY; Hwang, YK; Hoeres, T; Boxhammer, R; Heitmueller, C; Wilhelm, M; Steidl, S; Endell, J
CANCER IMMUNOL IMMUN. 2022;
Originalarbeiten (Zeitschrift)

MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
Heugenhauser, J; Galijasevic, M; Mangesius, S; Goebel, G; Buchroithner, J; Erhart, F; Pichler, J; Widhalm, G; Stockhammer, G; Iglseder, S; Freyschlag, CF; Oberndorfer, S; Bordihn, K; von Campe, G; Czech, T; Surbock, B; Purkart, TU; Marosi, C; Felzmann, T; Nowosielski, M
CANCERS. 2022; 14(6): 1579
Originalarbeiten (Zeitschrift)

MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.
Kreft, S; Glutsch, V; Zaremba, A; Schummer, P; Mohr, P; Grimmelmann, I; Gutzmer, R; Meier, F; Pföhler, C; Sachse, MM; Meiss, F; Forschner, A; Haferkamp, S; Welzel, J; Terheyden, P; Herbst, R; Utikal, J; Kaatz, M; Weishaupt, C; Kreuter, A; Debus, D; Duecker, P; Sindrilaru, A; Löffler, H; Schley, G; Weichenthal, M; Schadendorf, D; Ugurel, S; Gesierich, A; Schilling, B;
Eur J Cancer. 2022; 167: 32-41.
Originalarbeiten (Zeitschrift)

Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma.
Laukhtina, E; Hassler, MR; Pradere, B; Yanagisawa, T; Quhal, F; Rajwa, P; Sari Motlagh, R; König, F; Pallauf, M; Kawada, T; Mostafaei, H; D"Andrea, D; Enikeev, D; Shariat, SF;
Eur Urol Focus. 2022; 8(6): 1683-1686.
Übersichtsarbeiten

New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) of unknown aetiology: A comparison of the incomparable?
Nausch, E; Schaffeldt, L; Tautorat, I; Margraf, NG; Häusler, M; Kluger, G; Kellinghaus, C; Borzikowsky, C; Laufs, H; van Baalen, A;
Seizure. 2022; 96:18-21
Originalarbeiten (Zeitschrift)

Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis
Oswald, D; Pallauf, M; Deininger, S; Torzsok, P; Sieberer, M; Eiben, C
CANCERS. 2022; 14(19): 4841
Übersichtsarbeiten

Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Rischin, D; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; de Castro, G; Psyrri, A; Brana, I; Neupane, P; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Hong, RL; Mendoza, RG; Jia, LY; Chirovsky, D; Norquist, J; Jin, F; Burtness, B
ORAL ONCOL. 2022; 128: 105815
Originalarbeiten (Zeitschrift)

How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.
Roeder, F; Gerum, S; Hecht, S; Huemer, F; Jäger, T; Kaufmann, R; Klieser, E; Koch, OO; Neureiter, D; Emmanuel, K; Sedlmayer, F; Greil, R; Weiss, L;
Cancers (Basel). 2022; 14(22):
Übersichtsarbeiten

Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L;
BMC Cancer. 2022; 22(1): 51
Originalarbeiten (Zeitschrift)

Prognostic value of 2-[ 18 F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy
Schweighofer-Zwink, G; Manafi-Farid, R; Kölblinger, P; Hehenwarter, L; Harsini, S; Pirich, C; Beheshti, M;
Eur J Radiol. 2022; 146: 110107
Originalarbeiten (Zeitschrift)

Carbon Monoxide Diffusing Capacity (DL
Stana, M; Grambozov, B; Gaisberger, C; Karner, J; Ruznic, E; Berchtold, J; Zellinger, B; Moosbrugger, R; Studnicka, M; Fastner, G; Sedlmayer, F; Zehentmayr, F;
Diagnostics (Basel). 2022; 12(5):
Originalarbeiten (Zeitschrift)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
Starzer, AM; Heller, G; Tomasich, E; Melchardt, T; Feldmann, K; Hatziioannou, T; Traint, S; Minichsdorfer, C; Schwarz-Nemec, U; Nackenhorst, M; Mullauer, L; Preusser, M; Berghoff, AS; Fuereder, T
J IMMUNOTHER CANCER. 2022; 10(3): e003420
Originalarbeiten (Zeitschrift)

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.
Altunay, B; Morgenroth, A; Beheshti, M; Vogg, A; Wong, NCL; Ting, HH; Biersack, HJ; Stickeler, E; Mottaghy, FM;
Eur J Nucl Med Mol Imaging. 2021; 48(5):137-1389
Übersichtsarbeiten

Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy.
Chaudhuri, KR; Rukavina, K; McConvey, V; Antonini, A; Lorenzl, S; Bhidayasiri, R; Piemonte, MEP; Lim, SY; Richfield, E; Walker, R; Bouca-Machado, R; Bajwah, S; Gao, W; Trivedi, D; Miyasaki, J
EXPERT REV NEUROTHER. 2021; 17(6): 643-659.
Originalarbeiten (Zeitschrift)

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.
Grambozov, B; Wass, R; Stana, M; Gerum, S; Karner, J; Fastner, G; Studnicka, M; Sedlmayer, F; Zehentmayr, F
THORAC CANCER. 2021; 12(8): 1162-1170.
Originalarbeiten (Zeitschrift)

Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.
Korotchenko, E; Schießl, V; Scheiblhofer, S; Schubert, M; Dall, E; Joubert, IA; Strandt, H; Neuper, T; Sarajlic, M; Bauer, R; Geppert, M; Joedicke, D; Wildner, S; Schaller, S; Winkler, S; Gadermaier, G; Horejs-Hoeck, J; Weiss, R;
Allergy. 2021; 76(1):210-222
Originalarbeiten (Zeitschrift)

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
Kroeze, SGC; Fritz, C; Schaule, J; Siva, S; Kahl, KH; Sundahl, N; Blanck, O; Kaul, D; Adebahr, S; Verhoeff, JJC; Skazikis, G; Roeder, F; Geier, M; Eckert, F; Guckenberger, M;
BJU Int. 2021; 127(6):703-711
Originalarbeiten (Zeitschrift)

Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the TOaSTT database.
Kroeze, SGC; Schaule, J; Fritz, C; Kaul, D; Blanck, O; Kahl, KH; Roeder, F; Siva, S; Verhoeff, JJC; Adebahr, S; Schymalla, MM; Glatzer, M; Szuecs, M; Geier, M; Skazikis, G; Sackerer, I; Lohaus, F; Eckert, F; Guckenberger, M;
Radiat Oncol. 2021; 16(1):4
Originalarbeiten (Zeitschrift)

Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.
Lang, D; Brauner, A; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Kaiser, B; Greil, R; Lamprecht, B;
Cancers (Basel). 2021; 14(1):
Originalarbeiten (Zeitschrift)

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Magnes, T; Wagner, SM; Melchardt, T; Weiss, L; Rinnerthaler, G; Huemer, F; Kopp, M; Gampenrieder, SP; Mayrbäurl, B; Füreder, T; Lenger, D; Andel, J; Egle, A; Greil, R;
Wien Klin Wochenschr. 2021; 133(21-22):-1136.
Originalarbeiten (Zeitschrift)

The challenges of combinatory immunotherapy for biliary tract cancer.
Neureiter, D; Mayr, C; Kiesslich, T;
Expert Opin Investig Drugs. 2021; 30(6):591-594
Editorials

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.
Ocker, M; Mayr, C; Kiesslich, T; Stintzing, S; Neureiter, D;
Cancers (Basel). 2021; 13(7):
Übersichtsarbeiten

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
Ressler, JM; Karasek, M; Koch, L; Silmbrod, R; Mangana, J; Latifyan, S; Aedo-Lopez, V; Kehrer, H; Weihsengruber, F; Koelblinger, P; Posch, C; Kofler, J; Michielin, O; Richtig, E; Hafner, C; Hoeller, C
J IMMUNOTHER CANCER. 2021; 9(2):
Originalarbeiten (Zeitschrift)

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature.
Schlick, K; Kiem, D; Greil, R;
Biomolecules. 2021; 11(10):
Übersichtsarbeiten

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Semrau, S; Gostian, AO; Traxdorf, M; Eckstein, M; Rutzner, S; von der Grün, J; Illmer, T; Hautmann, M; Klautke, G; Laban, S; Brunner, T; Tamaskovics, B; Frey, B; Zhou, JG; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, U; Iro, H; Fietkau, R; Hecht, M;
Cancers (Basel). 2021; 13(8):
Originalarbeiten (Zeitschrift)

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Stege, H; Haist, M; Schultheis, M; Fleischer, MI; Mohr, P; Meier, F; Schadendorf, D; Ugurel, S; Livingstone, E; Zimmer, L; Herbst, R; Pfohler, C; Kahler, K; Weichenthal, M; Terheyden, P; Nashan, D; Debus, D; Kaatz, M; Ziller, F; Haferkamp, S; Forschner, A; Leiter, U; Kreuter, A; Ulrich, J; Kleemann, J; Bradfisch, F; Grabbe, S; Loquai, C
CANCERS. 2021; 13(10):
Originalarbeiten (Zeitschrift)

β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.
Sturm, GJ; Herzog, SA; Aberer, W; Arias, TA; Antolin-Amerigo, D; Bonadonna, P; Boni, E; Bozek, A; Chelminska, M; Ernst, B; Frelih, N; Gawlik, R; Gelincik, A; Hawranek, T; Hoetzenecker, W; Blanco, AJ; Kita, K; Kendirlinan, R; Kosnik, M; Laipold, K; Lang, R; Marchi, F; Mauro, M; Nittner-Marszalska, M; Poziomkowska-Gesicka, I; Pravettoni, V; Preziosi, D; Quercia, O; Reider, N; Rosiek-Biegus, M; Ruiz-Leon, B; Schrautzer, C; Serrano, P; Sin, A; Sin, BA; Stoevesandt, J; Trautmann, A; Vachova, M; Arzt-Gradwohl, L
ALLERGY. 2021; 76(7): 2166-2176.
Originalarbeiten (Zeitschrift)

Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.
Tsiogka, A; Bauer, JW; Patsatsi, A
ACTA DERM-VENEREOL. 2021; 101(1): adv00377
Übersichtsarbeiten

Acrometastases to the Hand: A Systematic Review.
Umana, GE; Scalia, G; Palmisciano, P; Passanisi, M; Da Ros, V; Pompili, G; Barone, F; Amico, P; Tomasi, SO; Graziano, F; Patti, IV; Mele, S; Maugeri, R; Raffa, G; Giammalva, GR; Iacopino, GD; Germanò, A; Nicoletti, GF; Ippolito, M; Sabini, MG; Cicero, S; Strigari, L; Cuttone, G;
Medicina (Kaunas). 2021; 57(9):
Übersichtsarbeiten

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
Wagner, NB; Lenders, MM; Kühl, K; Reinhardt, L; André, F; Dudda, M; Ring, N; Ebel, C; Stäger, R; Zellweger, C; Lang, R; Paar, M; Gussek, P; Richtig, G; Stürmer, SH; Kimeswenger, S; Oellinger, A; Forschner, A; Leiter, U; Weide, B; Gassenmaier, M; Schraag, A; Klumpp, B; Hoetzenecker, W; Berking, C; Richtig, E; Ziemer, M; Mangana, J; Terheyden, P; Loquai, C; Nguyen, VA; Gebhardt, C; Meier, F; Diem, S; Cozzio, A; Flatz, L; Röcken, M; Garbe, C; Eigentler, TK;
J Immunother Cancer. 2021; 9(5):
Originalarbeiten (Zeitschrift)

ASCO 2021-an update on metastastic colorectal cancer
Weiss, L
MEMO-MAG EUR MED ONC. 2021;
Übersichtsarbeiten

Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina.
Wohlmuth, C; Wohlmuth-Wieser, I; Laframboise, S;
J Low Genit Tract Dis. 2021; 25(2):146-151
Originalarbeiten (Zeitschrift)

Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF
Zimmer, L; Livingstone, E; Krackhardt, A; Schultz, ES; Goppner, D; Assaf, C; Trebing, D; Stelter, K; Windemuth-Kieselbach, C; Ugurel, S; Schadendorf, D
Eur J Cancer. 2021; 158:72-84
Originalarbeiten (Zeitschrift)

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
Amaral, T; Kiecker, F; Schaefer, S; Stege, H; Kaehler, K; Terheyden, P; Gesierich, A; Gutzmer, R; Haferkamp, S; Uttikal, J; Berking, C; Rafei-Shamsabadi, D; Reinhardt, L; Meier, F; Karoglan, A; Posch, C; Gambichler, T; Pfoehler, C; Thoms, K; Tietze, J; Debus, D; Herbst, R; Emmert, S; Loquai, C; Hassel, JC; Meiss, F; Tueting, T; Heinrich, V; Eigentler, T; Garbe, C; Zimmer, L
J IMMUNOTHER CANCER. 2020; 8(1):
Originalarbeiten (Zeitschrift)

Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study.
Bozzetti, S; Rossini, F; Ferrari, S; Delogu, R; Cantalupo, G; Marchioretto, F; Zanette, G; Zanoni, T; Turatti, M; Vitale, G; Cadaldini, M; Rossi, F; Di Tizio, L; Zuco, C; Maniscalco, GT; Soldani, F; Monaco, S; Trinka, E; Hoeftberger, R; Mariotto, S;
J Neurol Neurosurg Psychiatry. 2020; 91(11): 1145-1153.
Originalarbeiten (Zeitschrift)

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).
Brueckl, WM; Ficker, JH; Zeitler, G
BMC CANCER. 2020; 20(1): 1185
Übersichtsarbeiten

Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options.
Gampenrieder, SP; Castagnaviz, V; Rinnerthaler, G; Greil, R
CANCER MANAG RES. 2020; 12: 10615-10629.
Übersichtsarbeiten

Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke, S; Ortner, D; Szenes-Nagy, AB; Zaborsky, N; Weiss, R; Neureiter, D; Wipplinger, M; Risch, A; Hammerl, P; Greil, R; Sibilia, M; Gratz, IK; Stoitzner, P; Aberger, F;
Mol Oncol. 2020; 14(9):1930-1946
Originalarbeiten (Zeitschrift)

Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.
Haferkamp, S; Alter, M; Debus, D; Schilling, B; Pinter, A; Terheyden, P; Utikal, JS; Sachse, MM; Haalck, T; Wolf, IH;
Adv Ther. 2020; 37(8): 361-3629.
Originalarbeiten (Zeitschrift)

Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease.
Joubert, AI; Geppert, M; Johnson, L; Mills-Goodlet, R; Michelini, S; Korotchenko, E; Duschl, A; Weiss, R; Horejs-Höck, J; Himly, M;
Front Immunol. 2020; 11: 1334
Übersichtsarbeiten

Laser-facilitated epicutaneous immunotherapy with depigmented house dust mite extract alleviates allergic responses in a mouse model of allergic lung inflammation.
Korotchenko, E; Moya, R; Scheiblhofer, S; Joubert, IA; Horejs-Hoeck, J; Hauser, M; Calzada, D; Iraola, V; Carnés, J; Weiss, R;
Allergy. 2020; 75(5): 1217-1228.
Originalarbeiten (Zeitschrift)

Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
Ludwig, SV; F Cheng, P; Mangana, J; Braun, R; Dummer, R; Koelblinger, P;
Eur J Dermatol. 2020; 30(6): 6-709.
Originalarbeiten (Zeitschrift)

The role of TH17 cells in multiple sclerosis: Therapeutic implications.
Moser, T; Akgün, K; Proschmann, U; Sellner, J; Ziemssen, T;
Autoimmun Rev. 2020; 19(10):102647
Übersichtsarbeiten

Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Otto, F; Moser, T; Feige, J; Seiberl, M; Bieler, L; Sellner, J;
Mult Scler Relat Disord. 2020; 42: 102108
Fallberichte

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F;
Cancers (Basel). 2020; 12(8):
Originalarbeiten (Zeitschrift)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule, J; Kroeze, SGC; Blanck, O; Stera, S; Kahl, KH; Roeder, F; Combs, SE; Kaul, D; Claes, A; Schymalla, MM; Adebahr, S; Eckert, F; Lohaus, F; Abbasi-Senger, N; Henke, G; Szuecs, M; Geier, M; Sundahl, N; Buergy, D; Dummer, R; Guckenberger, M;
Radiat Oncol. 2020; 15(1):135
Originalarbeiten (Zeitschrift)

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.
Seliger, B; Massa, C; Yang, B; Bethmann, D; Kappler, M; Eckert, AW; Wickenhauser, C;
Int J Mol Sci. 2020; 21(19):
Übersichtsarbeiten

Immunological consequences of "immune reconstitution therapy" in multiple sclerosis: A systematic review.
Sellner, J; Rommer, PS
AUTOIMMUN REV. 2020; 19(4): 102492
Übersichtsarbeiten

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.
Valent, P; Akin, C; Bonadonna, P; Brockow, K; Niedoszytko, M; Nedoszytko, B; Butterfield, JH; Alvarez-Twose, I; Sotlar, K; Schwaab, J; Jawhar, M; Reiter, A; Castells, M; Sperr, WR; Kluin-Nelemans, HC; Hermine, O; Gotlib, J; Zanotti, R; Broesby-Olsen, S; Horny, HP; Triggiani, M; Siebenhaar, F; Orfao, A; Metcalfe, DD; Arock, M; Hartmann, K
J ALLERGY CLIN IMMUN. 2020; 146(2): 300-306.
Originalarbeiten (Zeitschrift)

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.
da Silva, IP; Glitza, IC; Haydu, LE; Johnpulle, R; Banks, PD; Grass, GD; Goldinger, SMA; Smith, JL; Everett, AS; Koelblinger, P; Roberts-Thomson, R; Millward, M; Atkinson, VG; Guminski, A; Kapoor, R; Conry, RM; Carlino, MS; Wang, W; Shackleton, MJ; Eroglu, Z; Lo, S; Hong, AM; Long, GV; Johnson, DB; Menzies, AM
PIGM CELL MELANOMA R. 2019; 32(4): 553-563.
Originalarbeiten (Zeitschrift)

Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.
Erhart, F; Weiss, T; Klingenbrunner, S; Fischhuber, K; Reitermaier, R; Halfmann, A; Blauensteiner, B; Lötsch, D; Spiegl-Kreinecker, S; Berger, W; Sialana, FJ; Lubec, G; Felzmann, T; Dohnal, A; Visus, C;
Cytotherapy. 2019; 21(6): 643-658.
Originalarbeiten (Zeitschrift)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
Neureiter, D; Stintzing, S; Kiesslich, T; Ocker, M
WORLD J GASTROENTERO. 2019; 25(25): 3136-3150.
Übersichtsarbeiten

Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Pichler, R; Comperat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M
CANCERS. 2019; 11(3): 422
Übersichtsarbeiten

Epidermolysis bullosa: Advances in research and treatment.
Prodinger, C; Reichelt, J; Bauer, JW; Laimer, M;
Exp Dermatol. 2019; 28(10):1176-1189
Übersichtsarbeiten

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Buchroithner, J; Erhart, F; Pichler, J; Widhalm, G; Preusser, M; Stockhammer, G; Nowosielski, M; Iglseder, S; Freyschlag, CE; Oberndorfer, S; Bordihn, K; von Campe, G; Hoffermann, M; Ruckser, R; Rossler, K; Spiegl-Kreinecker, S; Fischer, MB; Czech, T; Visus, C; Krumpl, G; Felzmann, T; Marosi, C
Cancers (Basel). 2018; 10(10):
Originalarbeiten (Zeitschrift)

Tolerogenic Dendritic Cells Reduce Airway Inflammation in a Model of Dust Mite Triggered Allergic Inflammation.
de Aragão-França, LS; Aragão-França, LS; Rocha, VCJ; Rocha, VCJ; Cronemberger-Andrade, A; da Costa, FHB; Costa, FHB; Vasconcelos, ; Vasconcelos, JF; Athanazio, DA; Silva, DN; Santos, ES; Santos, ES; Meira, CS; Araujo, CF; Araújo, CF; Cerqueira, JV; Cardillo, F; Alcântara-Neves, NM; Soares, MBP; Pontes de Carvalho, LC; Pontes-de-Carvalho, LC;
Allergy Asthma Immunol Res. 2018; 10(4): 406-419.
Originalarbeiten (Zeitschrift)

Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection.
Friebe, A; Siegling, A; Weber, O;
J Microbiol Immunol Infect. 2018; 51(5):587-592
Originalarbeiten (Zeitschrift)

Improving the Efficiency of V gamma 9V delta 2 T Cell Immunotherapy in Cancer
Hoeres, T; Smetak, M; Pretscher, D; Wilhelm, M
FRONT IMMUNOL. 2018; 9: 800
Übersichtsarbeiten

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S; Lang, R; Steiner, M; Aglas, L; Ferreira, F; Wallner, M; Hawranek, T; Gadermaier, G;
Clin Transl Allergy. 2018; 8: 39
Originalarbeiten (Zeitschrift)

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimers disease.
Novak, P; Schmidt, R; Kontsekova, E; Kovacech, B; Smolek, T; Katina, S; Fialova, L; Prcina, M; Parrak, V; Dal-Bianco, P; Brunner, M; Staffen, W; Rainer, M; Ondrus, M; Ropele, S; Smisek, M; Sivak, R; Zilka, N; Winblad, B; Novak, M;
Alzheimers Res Ther. 2018; 10(1): 108
Originalarbeiten (Zeitschrift)

Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysis.
Santoni, M; Conti, A; Buti, S; Bersanelli, M; Foghini, L; Piva, F; Giulietti, M; Lusuardi, L; Battelli, N
IMMUNOTHERAPY-UK. 2018; 10(15): 1303-1313.
Übersichtsarbeiten

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy.
Valovirta, E; Petersen, TH; Piotrowska, T; Laursen, MK; Andersen, JS; Sørensen, HF; Klink, R;
J Allergy Clin Immunol. 2018; 141(2): 529-538.e13.
Originalarbeiten (Zeitschrift)

Cure in metastatic breast cancer.
Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Greil, R;
Memo. 2018; 11(3):172-179
Übersichtsarbeiten

T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Catakovic, K; Klieser, E; Neureiter, D; Geisberger, R;
Cell Commun Signal. 2017; 15(1):
Übersichtsarbeiten

MEK inhibition and immune responses in advanced melanoma
Dummer, R; Ramelyte, E; Schindler, S; Thurigen, O; Levesque, MP; Koelblinger, P
ONCOIMMUNOLOGY. 2017; 6(8): e1335843
Übersichtsarbeiten

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.
Egle, A
MEMO-MAG EUR MED ONC. 2017; 10(1): 8-12.
Übersichtsarbeiten

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.
Gross, S; Erdmann, M; Haendle, I; Voland, S; Berger, T; Schultz, E; Strasser, E; Dankerl, P; Janka, R; Schliep, S; Heinzerling, L; Sotlar, K; Coulie, P; Schuler, G; Schuler-Thurner, B;
JCI Insight. 2017; 2(8):
Originalarbeiten (Zeitschrift)

Expression and Characterization of Functional Recombinant Bet v 1.0101 in the Chloroplast of Chlamydomonas reinhardtii.
Hirschl, S; Ralser, C; Asam, C; Gangitano, A; Huber, S; Ebner, C; Bohle, B; Wolf, M; Briza, P; Ferreira, F; Griesbeck, C; Wallner, M;
Int Arch Allergy Immunol. 2017; 173(1): 44-50.
Originalarbeiten (Zeitschrift)

Comparing Proteolytic Fingerprints of Antigen-Presenting Cells during Allergen Processing.
Hofer, H; Weidinger, T; Briza, P; Asam, C; Wolf, M; Twaroch, TE; Stolz, F; Neubauer, A; Dall, E; Hammerl, P; Jacquet, A; Wallner, M;
Int J Mol Sci. 2017; 18(6):
Originalarbeiten (Zeitschrift)

Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266:87-99
Originalarbeiten (Zeitschrift)

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.
Magnes, T; Egle, A; Greil, R; Melchardt, T;
MEMO-MAG EUR MED ONC. 2017; 10(4): 220-223.
Übersichtsarbeiten

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer"s disease: a randomised, double-blind, placebo-controlled, phase 1 trial.
Novak, P; Schmidt, R; Kontsekova, E; Zilka, N; Kovacech, B; Skrabana, R; Vince-Kazmerova, Z; Katina, S; Fialova, L; Prcina, M; Parrak, V; Dal-Bianco, P; Brunner, M; Staffen, W; Rainer, M; Ondrus, M; Ropele, S; Smisek, M; Sivak, R; Winblad, B; Novak, M;
Lancet Neurol. 2017; 16(2):123-134
Originalarbeiten (Zeitschrift)

Amb a 1 isoforms: Unequal siblings with distinct immunological features.
Wolf, M; Twaroch, TE; Huber, S; Reithofer, M; Steiner, M; Aglas, L; Hauser, M; Aloisi, I; Asam, C; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Jahn-Schmid, B; Wallner, M; Ferreira, F;
Allergy. 2017; 72(12): 1874-1882.
Originalarbeiten (Zeitschrift)

Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation.
Deloch, L; Derer, A; Hartmann, J; Frey, B; Fietkau, R; Gaipl, US;
Front Oncol. 2016; 6:141
Übersichtsarbeiten

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik, MA; Jaeger, U; Petzer, A; Willenbacher, W; Keil, F; Lang, A; Andel, J; Burgstaller, S; Krieger, O; Oberaigner, W; Sihorsch, K; Greil, R;
Eur J Cancer. 2016; 58:-21
Originalarbeiten (Zeitschrift)

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Greil, R; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Fridrik, M; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Pleyer, L; Melchardt, T; Klingler, A; Mayer, J; Egle, A;
Lancet Haematol. 2016; 3(7):e317-e329
Originalarbeiten (Zeitschrift)

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Heinzerling, L; Ott, PA; Hodi, FS; Husain, AN; Tajmir-Riahi, A; Tawbi, H; Pauschinger, M; Gajewski, TF; Lipson, EJ; Luke, JJ
J IMMUNOTHER CANCER. 2016; 4: 50
Originalarbeiten (Zeitschrift)

Immune checkpoint blockade in ovarian cancer.
Weiss, L; Huemer, F; Mlineritsch, B; Greil, R;
Memo. 2016; 9:82-84
Übersichtsarbeiten

Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series.
Dogan Onugoren, M; Deuretzbacher, D; Haensch, CA; Hagedorn, HJ; Halve, S; Isenmann, S; Kramme, C; Lohner, H; Melzer, N; Monotti, R; Presslauer, S; Schäbitz, WR; Steffanoni, S; Stoeck, K; Strittmatter, M; Stögbauer, F; Trinka, E; von Oertzen, TJ; Wiendl, H; Woermann, FG; Bien, CG;
J Neurol Neurosurg Psychiatry. 2015; 86(9): 965-972.
Originalarbeiten (Zeitschrift)

Preliminary results of the global audit of treatment of refractory status epilepticus.
Ferlisi, M; Hocker, S; Grade, M; Trinka, E; Shorvon, S
Epilepsy Behav. 2015; 49:318-324
Originalarbeiten (Zeitschrift)

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.
Gassner, FJ; Zaborsky, N; Catakovic, K; Rebhandl, S; Huemer, M; Egle, A; Hartmann, TN; Greil, R; Geisberger, R;
Br J Haematol. 2015; 170(4):515-522
Originalarbeiten (Zeitschrift)

28-Year Survival following Several Metastasectomies, Going through 8th Line Systemic Therapy in a Case of mRCC.
Magdy, A; Bretterbauer, K; Hruby, S; Kunit, T; Colleselli, D; Janetschek, G; Mitterberger, M;
Case Rep Urol. 2015; 2015: 523258
Fallberichte

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A;
Br J Haematol. 2015; 168(2):239-245
Originalarbeiten (Zeitschrift)

Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A;
J Natl Compr Canc Netw. 2015; 13(12):1501-1508
Originalarbeiten (Zeitschrift)

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases
Pfaar, O; Bachert, C; Bufe, A; Buhl, R; Ebner, C; Eng, P; Friedrichs, F; Fuchs, T; Hamelmann, E; Hartwig-Bade, D; Hering, T; Huttegger, I; Jung, K; Klimek, L; Kopp, MV; Merk, H; Rabe, U; Saloga, J; Schmid-Grendelmeier, P; Schuster, A; Schwerk, N; Sitter, H; Unnpfenbach, U; Wedi, B; Wohrl, S; Worm, M; Kleine-Tebbe, J; Kaul, S; Schwalfenberg, A
ALLERGOLOGIE. 2015; 38(9): 431-470.
Originalarbeiten (Zeitschrift)

Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen, HJ; Poepperl, G; Goetz, C; Gildehaus, FJ; Schmidt, M; Tatsch, K; Pietsch, T; Kraus, T; Rachinger, W;
J Neurosurg. 2015; 123(3):76-70
Originalarbeiten (Zeitschrift)

A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).
Safi, S; Beckhove, P; Warth, A; Benner, A; Roeder, F; Rieken, S; Debus, J; Dienemann, H; Hoffmann, H; Huber, PE;
BMC Cancer. 2015; 15:988
Originalarbeiten (Zeitschrift)

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Butts, C; Socinski, MA; Mitchell, PL; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, TE; Bosquée, L; Trigo, JM; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Wickart-Johansson, G; Ellis, P; Gladkov, O; Pereira, JR; Eberhardt, WE; Helwig, C; Schröder, A; Shepherd, FA;
Lancet Oncol. 2014; 15(1): 59-68.
Originalarbeiten (Zeitschrift)

Molecular approach to allergy diagnosis and therapy.
Ferreira, F; Wolf, M; Wallner, M;
Yonsei Med J. 2014; 55(4): 839-852.
Übersichtsarbeiten

First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation
Geyeregger, R; Freimuller, C; Stemberger, J; Artwohl, M; Witt, V; Lion, T; Fischer, G; Lawitschka, A; Ritter, J; Hummel, M; Holter, W; Fritsch, G; Matthes-Martin, S
J IMMUNOTHER. 2014; 37(4): 245-249.
Originalarbeiten (Zeitschrift)

From the nucleus to the plasma membrane: translocation of the nuclear proteins histone H3 and lamin B1 in apoptotic microglia.
Klein, B; Lütz-Meindl, U; Kerschbaum, HH;
Apoptosis. 2014; 19(5): 759-775.
Originalarbeiten (Zeitschrift)

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.
Bezan, A; Hohla, F; Meissnitzer, T; Greil, R;
BMC Cancer. 2013; 13(1): 618
Fallberichte

The role of the e3 ligase cbl-B in murine dendritic cells.
Wallner, S; Lutz-Nicoladoni, C; Tripp, CH; Gastl, G; Baier, G; Penninger, JM; Stoitzner, P; Wolf, D
PLoS One. 2013; 8(6):e65178
Originalarbeiten (Zeitschrift)

Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice
Bach, D; Weiss, R; Hessenberger, M; Kitzmueller, S; Weinberger, EE; Krautgartner, WD; Hauser-Kronberger, C; Boehler, C; Thalhamer, J; Scheiblhofer, S
ALLERGY. 2012; 67(11): 1365-1374.
Originalarbeiten (Zeitschrift)

Tumor-promoting Versus Tumor-antagonizing Roles of gamma delta T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Kunzmann, V; Smetak, M; Kimmel, B; Weigang-Koehler, K; Goebeler, M; Birkmann, J; Becker, J; Schmidt-Wolf, IGH; Einsele, H; Wilhelm, M
J IMMUNOTHER. 2012; 35(2): 205-213.
Originalarbeiten (Zeitschrift)

Febrile Infection-Related Epilepsy Syndrome without Detectable Autoantibodies and Response to Immunotherapy: A Case Series and Discussion of Epileptogenesis in FIRES
van Baalen, A; Hausler, M; Plecko-Startinig, B; Strautmanis, J; Vlaho, S; Gebhardt, B; Rohr, A; Abicht, A; Kluger, G; Stephani, U; Probst, C; Vincent, A; Bien, CG
NEUROPEDIATRICS. 2012; 43(4): 209-216.
Originalarbeiten (Zeitschrift)

Inactivated orf virus (Parapoxvirus ovis) induces antitumoral activity in transplantable tumor models.
Fiebig, HH; Siegling, A; Volk, HD; Friebe, A; Knolle, P; Limmer, A; Weber, O;
Anticancer Res. 2011; 31(12):4185-4190
Originalarbeiten (Zeitschrift)

Characterization of plant food allergens: an overview on physicochemical and immunological techniques.
Harrer, A; Egger, M; Gadermaier, G; Erler, A; Hauser, M; Ferreira, F; Himly, M;
Mol Nutr Food Res. 2010; 54(1): 93-112.
Übersichtsarbeiten

Specific immunotherapy (hyposensitization) for IgE-mediated allergic diseases
Kleine-Tebbe, J; Bufe, A; Ebner, C; Eigenmann, P; Friedrichs, F; Fuchs, T; Huttegger, I; Jung, K; Klimek, L; Kopp, M; Lassig, W; Merk, H; Niggemann, B; Rabe, U; Saloga, J; Schmid-Grendelmeier, P; Sitter, H; Virchow, JC; Wagenmann, M; Wedi, B; Worm, M; Hering, T; Koch, A; Lenders, H; Musken, H; Schnitzer, S; Stuck, BA; Voigtmann, I; Wehrmann, W; Kaul, S; Luther, B; Schwalfenberg, A
ALLERGOLOGIE. 2010; 33(1): 3-+.
Übersichtsarbeiten

Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
Ruëff, F; Przybilla, B; Biló, MB; Müller, U; Scheipl, F; Aberer, W; Birnbaum, J; Bodzenta-Lukaszyk, A; Bonifazi, F; Bucher, C; Campi, P; Darsow, U; Egger, C; Haeberli, G; Hawranek, T; Kucharewicz, I; Küchenhoff, H; Lang, R; Quercia, O; Reider, N; Severino, M; Sticherling, M; Sturm, GJ; Wüthrich, B;
J ALLERGY CLIN IMMUN. 2010; 126(1): 10-11.e5.
Originalarbeiten (Zeitschrift)

Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.
Thalhamer, T; Dobias, H; Stepanoska, T; Pröll, M; Stutz, H; Dissertori, O; Lackner, P; Ferreira, F; Wallner, M; Thalhamer, J; Hartl, A;
J Allergy Clin Immunol. 2010; 125(4):926-934.e10
Originalarbeiten (Zeitschrift)

Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
Vollmar, P; Kullmann, JS; Thilo, B; Claussen, MC; Rothhammer, V; Jacobi, H; Sellner, J; Nessler, S; Korn, T; Hemmer, B;
J Immunol. 2010; 185(10): 6338-6347.
Originalarbeiten (Zeitschrift)

Antigen aggregation decides the fate of the allergic immune response.
Zaborsky, N; Brunner, M; Wallner, M; Himly, M; Karl, T; Schwarzenbacher, R; Ferreira, F; Achatz, G
J IMMUNOL. 2010; 184(2): 72-35.
Originalarbeiten (Zeitschrift)

[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].
Szépfalusi, Z; Emminger, W; Eitelberger, F; Götz, M; Grillenberger, A; Horak, E; Huttegger, I; Koller, D; Litscher, H; Schmitzberger, R; Varga, EM; Riedler, J;
Wien Klin Wochenschr. 2009; 121(19-20):648-660
Übersichtsarbeiten

Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen.
Jahn-Schmid, B; Sirven, P; Leb, V; Pickl, WF; Fischer, GF; Gadermaier, G; Egger, M; Ebner, C; Ferreira, F; Maillere, B; Bohle, B;
J IMMUNOL. 2008; 181(5): 3636-3642.
Originalarbeiten (Zeitschrift)

Tumour-immune cell interactions modulated by chemokines.
Jöhrer, K; Pleyer, L; Olivier, A; Maizner, E; Zelle-Rieser, C; Greil, R;
EXPERT OPIN BIOL TH. 2008; 8(3): 26-90.
Übersichtsarbeiten

[Immunization strategies for treating melanoma].
Schultz, ES; Schuler, G;
Hautarzt. 2008; 59(10):785-792
Übersichtsarbeiten

Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI)
Smetak, M; Kimmel, B; Birkmann, J; Schaefer-Eckart, K; Einsele, H; Wilhelm, M; Kunzmann, V
BONE MARROW TRANSPL. 2008; 41(7): 643-650.
Originalarbeiten (Zeitschrift)

Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy
Aberer, W; Hawranek, T; Reider, N; Schuster, C; Sturm, G; Kranke, B
J INVEST ALLERG CLIN. 2007; 17(3): 131-136.
Originalarbeiten (Zeitschrift)

Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy.
Scheiblhofer, S; Stoecklinger, A; Gruber, C; Hauser-Kronberger, C; Alinger, B; Hammerl, P; Thalhamer, J; Weiss, R;
MOL IMMUNOL. 2007; 44(8): 1879-1887.
Originalarbeiten (Zeitschrift)

Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy.
Bauer, R; Scheiblhofer, S; Kern, K; Gruber, C; Stepanoska, T; Thalhamer, T; Hauser-Kronberger, C; Alinger, B; Zoegg, T; Gabler, M; Ferreira, F; Hartl, A; Thalhamer, J; Weiss, R;
J Allergy Clin Immunol. 2006; 118(1):269-276
Originalarbeiten (Zeitschrift)

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.
Falkensammer, C; Jöhrer, K; Gander, H; Ramoner, R; Putz, T; Rahm, A; Greil, R; Bartsch, G; Thurnher, M;
Cancer Immunol Immunother. 2006; 55(10): 1228-1237.
Originalarbeiten (Zeitschrift)

Hymenoptera venom immunotherapy and field stings.
Lang, R; Hawranek, T;
J INVEST ALLERG CLIN. 2006; 16(4): 224-231.
Originalarbeiten (Zeitschrift)

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
Punt, CJ; Suciu, S; Gore, MA; Koller, J; Kruit, WH; Thomas, J; Patel, P; Lienard, D; Eggermont, AM; Keilholz, U;
Eur J Cancer. 2006; 42(17):2991-2995
Originalarbeiten (Zeitschrift)

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
Maczek, C; Berger, TG; Schuler-Thurner, B; Schultz, ES; Hamann, A; Dunbar, PR; Cerundolo, V; Steinkasserer, A; Schuler, G;
Int J Cancer. 2005; 115(3):450-455
Originalarbeiten (Zeitschrift)

[Malignant melanoma. Diagnosis and therapy].
Schultz, ES; Schuler, G;
HNO. 2005; 53(11):928-939
Übersichtsarbeiten

Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.
Focke, M; Linhart, B; Hartl, A; Wiedermann, U; Sperr, WR; Valent, P; Thalhamer, J; Kraft, D; Valenta, R;
Clin Exp Allergy. 2004; 34(10):1525-1533
Originalarbeiten (Zeitschrift)

Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
Heussinger, N; Büttner, M; Ott, G; Brachtel, E; Pilch, BZ; Kremmer, E; Niedobitek, G;
J Pathol. 2004; 203(2):696-699
Originalarbeiten (Zeitschrift)

Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
Mahler, V; Vrtala, S; Kuss, O; Diepgen, TL; Suck, R; Cromwell, O; Fiebig, H; Hartl, A; Thalhamer, J; Schuler, G; Kraft, D; Valenta, R
CLIN EXP ALLERGY. 2004; 34(1): 115-122.
Originalarbeiten (Zeitschrift)

Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen.
Bauer, R; Himly, M; Dedic, A; Ferreira, F; Thalhamer, J; Hartl, A;
Allergy. 2003; 58(10):1003-1010
Originalarbeiten (Zeitschrift)

Dendritic cell-based immunotherapy.
Berger, TG; Schultz, ES;
Curr Top Microbiol Immunol. 2003; 276: 163-197.
Übersichtsarbeiten

Strategies for the development of safe and effective DNA vaccines for allergy treatment.
Hartl, A; Weiss, R; Hochreiter, R; Scheiblhofer, S; Bauer, R; Valenta, R; Ferreira, F; Leitner, W; Thalhamer, J;
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003; (94): 27-98.
Übersichtsarbeiten

Catastrophic venous air embolus during prostatectomy in the Trendelenburg position.
Memtsoudis, SG; Malhotra, V;
Can J Anaesth. 2003; 50(10):1084-1085
Letter

Antigen loading of dendritic cells with whole tumor cell preparations.
Thumann, P; Moc, I; Humrich, J; Berger, TG; Schultz, ES; Schuler, G; Jenne, L;
J Immunol Methods. 2003; 277(1-2):-16
Originalarbeiten (Zeitschrift)

A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18.
Bilsborough, J; Panichelli, C; Duffour, MT; Warnier, G; Lurquin, C; Schultz, ES; Thielemans, K; Corthals, J; Boon, T; van der Bruggen, P;
Tissue Antigens. 2002; 60(1):16-24
Originalarbeiten (Zeitschrift)

Genetic engineering of allergens: future therapeutic products.
Ferreira, F; Wallner, M; Breiteneder, H; Hartl, A; Thalhamer, J; Ebner, C;
Int Arch Allergy Immunol. 2002; 128(3): 171-178.
Übersichtsarbeiten

Regulation of CD23 isoforms on B-chronic lymphocytic leukemia
Goller, ME; Kneitz, C; Mehringer, C; Muller, K; Jelley-Gibbs, DM; Gosselin, EJ; Wilhelm, M; Tony, HP
LEUKEMIA RES. 2002; 26(9): 795-802.
Originalarbeiten (Zeitschrift)

A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells.
Chaux, P; Lethé, B; Van Snick, J; Corthals, J; Schultz, ES; Cambiaso, CL; Boon, T; van der Bruggen, P;
Eur J Immunol. 2001; 31(6):1910-1916
Originalarbeiten (Zeitschrift)

The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase.
Hochreiter, R; Hartl, A; Freund, J; Valenta, R; Ferreira, F; Thalhamer, J;
Int Arch Allergy Immunol. 2001; 124(1-3): 406-410.
Originalarbeiten (Zeitschrift)

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.
Schultz, ES; Zhang, Y; Knowles, R; Tine, J; Traversari, C; Boon, T; van der Bruggen, P;
Tissue Antigens. 2001; 57(2):103-109
Originalarbeiten (Zeitschrift)

Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
Behr, TM; Blumenthal, RD; Memtsoudis, S; Sharkey, RM; Gratz, S; Becker, W; Goldenberg, DM;
Clin Cancer Res. 2000; 6(12):4900-4907
Originalarbeiten (Zeitschrift)

A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
Schultz, ES; Lethé, B; Cambiaso, CL; Van Snick, J; Chaux, P; Corthals, J; Heirman, C; Thielemans, K; Boon, T; van der Bruggen, P;
Cancer Res. 2000; 60(22):6272-6275
Originalarbeiten (Zeitschrift)

Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen.
Hartl, A; Kiesslich, J; Weiss, R; Bernhaupt, A; Mostböck, S; Scheiblhofer, S; Ebner, C; Ferreira, F; Thalhamer, J;
J Allergy Clin Immunol. 1999; 103(1 Pt 1):107-113
Originalarbeiten (Zeitschrift)

Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization.
Hartl, A; Kiesslich, J; Weiss, R; Bernhaupt, A; Mostböck, S; Scheiblhofer, S; Flöckner, H; Sippl, M; Ebner, C; Ferreira, F; Thalhamer, J;
Int Arch Allergy Immunol. 1999; 120(1):17-29
Originalarbeiten (Zeitschrift)

Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens.
Balda, BR; Wolf, H; Baumgarten, C; Klimek, L; Rasp, G; Kunkel, G; Müller, S; Mann, W; Hauswald, B; Heppt, W; Przybilla, B; Amon, U; Bischoff, R; Becher, G; Hummel, S; Frosch, PJ; Rustemeyer, T; Jäger, L; Brehler, R; Luger, T; Schnitker, J;
ALLERGY. 1998; 53(8): 740-748.
Originalarbeiten (Zeitschrift)

Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
Behr, TM; Memtsoudis, S; Sharkey, RM; Blumenthal, RD; Dunn, RM; Gratz, S; Wieland, E; Nebendahl, K; Schmidberger, H; Goldenberg, DM; Becker, W;
Int J Cancer. 1998; 77(5):787-795
Originalarbeiten (Zeitschrift)

[Brain metastases in renal cell carcinoma. Results of treatment and prognosis].
Pomer, S; Klopp, M; Steiner, HH; Brkovic, D; Staehler, G; Cabillin-Engenhart, R;
Urologe A. 1997; 36(2):117-125
Originalarbeiten (Zeitschrift)

Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
Zenner, HP; Baumgarten, C; Rasp, G; Fuchs, T; Kunkel, G; Hauswald, B; Ring, J; Effendy, I; Behrendt, W; Frosch, PJ; Przybilla, B; Brunner, FX; Merk, HF; Kapp, A; Schnitker, J; Wolf, H;
J ALLERGY CLIN IMMUN. 1997; 100(1): 23-29.
Originalarbeiten (Zeitschrift)

[Therapy of allergic rhinitis].
Rasp, G;
LARYNGO RHINO OTOL. 1993; 72(8): 373-378.
Übersichtsarbeiten